VC-funded Company:
Korsana Biosciences
221 Crescent Street¨ Building 23, Suite 105¨
Waltham, MA 02453
Phone: 781-516-2325
https://korsana.com/Korsana Biosciences was founded to reduce the burden of neurodegenerative diseases for patients and caregivers. In partnership with Paragon Therapeutics, Korsana has developed Therapeutic Targeting (THETA™), a novel blood-brain barrier-penetrant shuttle platform designed to enable dramatically higher drug concentration inside the brain and overcome the limitations of earlier shuttle technologies. Korsana is advancing a pipeline of innovative THETA-enabled therapies for neurodegenerative diseases, starting with KRSA-028 for the treatment of Alzheimer's disease.
Key Contact
Funding Events
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/18/26 | $175,000,000 | Seed and Series A |
Fairmount Funds Management Foresite Capital J.P. Morgan Janus Henderson Investors Sanofi Ventures TCGX Venrock Healthcare Partners Wellington Management Company | undisclosed |
